Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2)
| Autor: | Valentini, Vincenzo, Aristei, C, Glimelius, B, Minsky, Bd, Beets Tan, R, Borras, Jm, Haustermans, K, Maingon, P, Overgaard, J, Pahlman, L, Quirke, P, Schmoll, H, Sebag Montefiore, D, Taylor, I, Van Cutsem, E, Van De Velde, C, Cellini, Numa, Aranda, E, Latini, P, Blomqvist, L, Bosset, Jf, Brown, G, Bujko, K, Ectors, N, Gerard, Jp, Glynne Jones, R, Heald, R, Hohenberger, W, Holm, T, Laurberg, S, Leer, Jw, Marijnen, C, Nagtegaal, I, Rodel, C, Rutten, H, Scheithauer, W, Willet, Cg, Coco, Claudio, Gambacorta, Maria Antonietta, Genovesi, D, Lupattelli, M, Mantello, G, Valvo, E. |
|---|---|
| Přispěvatelé: | Laboratory of Molecular Cytogenetics and Mutagenesis, University of Tuscia, Carcinogénèse épithéliale : facteurs prédictifs et pronostiques - UFC ( CEF2P / CARCINO ), Centre Hospitalier Régional Universitaire [Besançon] ( CHRU Besançon ) -Université Bourgogne Franche-Comté ( UBFC ) -Université de Franche-Comté ( UFC ), Carcinogénèse épithéliale : facteurs prédictifs et pronostiques - UFC (EA 3181) (CEF2P / CARCINO), Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC)-Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon) |
| Jazyk: | angličtina |
| Rok vydání: | 2009 |
| Předmět: |
MESH: Combined Modality Therapy
Colorectal cancer Cost-Benefit Analysis Delphi method 030218 nuclear medicine & medical imaging Scientific evidence [ SDV.CAN ] Life Sciences [q-bio]/Cancer 0302 clinical medicine Multidisciplinary approach Risk Factors MESH: Risk Factors Voting MESH : Neoplasm Staging MESH : Rectal Neoplasms Settore MED/36 - DIAGNOSTICA PER IMMAGINI E RADIOTERAPIA media_common european consensus Hematology MESH: Neoplasm Staging Combined Modality Therapy MESH : Risk Factors 3. Good health Oncology 030220 oncology & carcinogenesis MESH : Cost-Benefit Analysis Sentence medicine.medical_specialty media_common.quotation_subject education MEDLINE [SDV.CAN]Life Sciences [q-bio]/Cancer cc2 MESH : Diet 03 medical and health sciences Quality of life (healthcare) eureca MESH: Diet medicine Humans Radiology Nuclear Medicine and imaging rectal cancer Neoplasm Staging Settore MED/06 - ONCOLOGIA MEDICA MESH: Humans business.industry Rectal Neoplasms MESH : Humans MESH: Quality of Life MESH: Rectal Neoplasms MESH : Quality of Life medicine.disease Surgery Diet Family medicine Quality of Life business MESH : Combined Modality Therapy MESH: Cost-Benefit Analysis |
| Zdroj: | Radiotherapy and Oncology Radiotherapy and Oncology, Elsevier, 2009, 92 (2), pp.148-163. 〈10.1016/j.radonc.2009.06.027〉 Radiotherapy and Oncology, Elsevier, 2009, 92 (2), pp.148-163. ⟨10.1016/j.radonc.2009.06.027⟩ Valentini, V, Aristei, C, Glimelius, B, Minsky, B D, Beets-Tan, R, Borras, J M, Haustermans, K, Maingon, P, Overgaard, J, Pahlman, L, Quirke, P, Schmoll, H-J, Sebag-Montefiore, D, Taylor, I, Van Cutsem, E, Van de Velde, C, Cellini, N & Latini, P 2009, ' Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2) ', Radiotherapy & Oncology, vol. 92, no. 2, pp. 148-63 . https://doi.org/10.1016/j.radonc.2009.06.027 |
| ISSN: | 0167-8140 |
| Popis: | International audience; BACKGROUND AND PURPOSE: During the first decade of the 21st century a number of important European randomized studies were published. In order to help shape clinical practice based on best scientific evidence from the literature, the International Conference on 'Multidisciplinary Rectal Cancer Treatment: Looking for an European Consensus' (EURECA-CC2) was organized in Italy under the endorsement of European Society of Medical Oncology (ESMO), European Society of Surgical Oncology (ESSO), and European Society of Therapeutic Radiation Oncology (ESTRO). METHODS: Consensus was achieved using the Delphi method. The document was available to all Committee members as a web-based document customized for the consensus process. Eight chapters were identified: epidemiology, diagnostics, pathology, surgery, radiotherapy and chemotherapy, treatment toxicity and quality of life, follow-up, and research questions. Each chapter was subdivided by a topic, and a series of statements were developed. Each member commented and voted, sentence by sentence thrice. Sentences upon which an agreement was not reached after voting round # 2 were openly debated during a Consensus Conference in Perugia (Italy) from 11 December to 13 December 2008. A hand-held televoting system collected the opinions of both the Committee members and the audience after each debate. The Executive Committee scored percentage consensus based on three categories: "large consensus", "moderate consensus", and "minimum consensus". RESULTS: The total number of the voted sentences was 207. Of the 207, 86% achieved large consensus, 13% achieved moderate consensus, and only 3 (1%) resulted in minimum consensus. No statement was disagreed by more than 50% of the members. All chapters were voted on by at least 75% of the members, and the majority was voted on by >85%. CONCLUSIONS: This Consensus Conference represents an expertise opinion process that may help shape future programs, investigational protocols, and guidelines for staging and treatment of rectal cancer throughout Europe. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect